Search

Author/Creator Italiano, A

2. 1288PSafety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma. (1st October 2019)

Authors:
Italiano, A; Cassier, P; Roda, D; Lin, C-C; Peltola, K; Gazzah, A; Shiah, H-S; Calvo, E; Tosi, D; Gao, B; warburton, L; Tanner, M; Englert, S; Lambert, S; Parikh, A; Afar, D; Vosganian, G; Moreno, V
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 1601ONatural history of sarcomas and impact of reference centers in the nationwide NETSARC study on 35, 784 patients (pts) from 2010 to 2017. (23rd October 2018)

Authors:
Blay, J-Y; Toulmonde, M; Penel, N; Mir, O; Chevreau, C M; Anract, P; Bompas, E; Rios, M; Firmin, N; Italiano, A; Piperno-Neumann, S; Kurtz, J-E; Duffaud, F; Rosset, P; Bertucci, F; Perrin, C; Chemin, C; Ducimetiere, F; Gouin, F; Le Cesne, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1608PDCan we cure patients with abdominal desmoplastic small round cell tumor? Results of a retrospective multicentric study on 100 patients. (23rd October 2018)

Authors:
Delhorme, J-B; Nassif, E; Ferron, G; Bompas, E; Adam, J; Glehen, O; Italiano, A; Bertucci, F; Orbach, D; Le Cesne, A; Blay, J Y; Chevreau, C M; Mir, O; Honoré, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 1611PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950). (23rd October 2018)

Authors:
Stacchiotti, S; Blay, J-Y; Jones, R L; Demetri, G D D; Mir, O; Italiano, A; Thomas, D; Chen, T W-W; Schöffski, P; Gil, T; Jahan, T; Cote, G; Ratan, R; Attia, S; Roche, M; Daigle, S; Sapir, I; Clawson, A; Gounder, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 1615PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950). (23rd October 2018)

Authors:
Gounder, M; Schöffski, P; Villalobos, V; Cote, G; Chugh, R; Chen, T W-W; Jahan, T; Loggers, E T; Italiano, A; Gupta, A; Agulnik, M; Attia, S; Jones, R L; van Tine, B A; Demetri, G D D; Roche, M; Sapir, I; Daigle, S; Clawson, A; Stacchiotti, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 182TiPEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors. (23rd October 2018)

Authors:
Italiano, A; Le Saux, O; André, F; Filleron, T; Spaeth, D; Heudel, P-E; Albiges, L; Bachelot, T; Gonçalves, A; Pierga, J-Y; Barlesi, F; Boige, V; Lebbe, C; Mortier, L; Frenel, J-S; Tredan, O; Jimenez, M; Legrand, F; Ferté, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 1892OMolecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950). (23rd October 2018)

Authors:
Daigle, S; Stacchiotti, S; Schöffski, P; Villalobos, V; Cote, G; Chugh, R; Chen, T W-W; Jahan, T; Loggers, E T; Italiano, A; Gupta, A; Agulnik, M; Attia, S; Jones, R L; van Tine, B A; Demetri, G D D; Clawson, A; Roche, M; Blakemore, S; Gounder, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours. (24th November 2019)

Authors:
Ziegler, D S; Doz, F; Geoerger, B; Dubois, S; Grilley-Olson, J E; van Tilburg, C; Italiano, A; Lissat, A; Kang, J-H; Tahara, M; Boni, V; Perreault, S; Capra, M; Nanda, S; Brega, N; Holynskyj, A; Hong, D S; Hyman, D; Drilon, A
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗